日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

抗BCMA CAR-T细胞疗法后CAR+T细胞淋巴瘤的靶向治疗

Aleman, Adolfo; Van Oekelen, Oliver; Melnekoff, David T; Grossman, Leah; Mouhieddine, Tarek H; Kurowski, Agata; Odak, Ivan; Reci, Sidorela; Desai, Shriya; Meledathu, Shannon; Naidu, Malini P; Shukla, Ravi P; Dutta, Rudra P; Kappes, Katerina; Serebryakova, Kseniya; Jackson, Hayley; Lu, Jordan; Chatikhine, Anastasia; Kulkarni, Raksha; Moinfar, Zahra; Croken, Matthew M; Mehrotra, Meenakshi; Baskovich, Brett; Rayamajhi, Sampanna; Richard, Shambavi; Rossi, Adriana C; Salib, Christian; Houldsworth, Jane; Brown, Brian D; Merad, Miriam; Laganà, Alessandro; Brunner, Patrick M; Jagannath, Sundar; Brody, Joshua D; Parekh, Samir

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation

美国国家癌症研究所关于免疫疗法与放射疗法联合应用的研讨会论文集:临床转化的挑战与机遇

Morris, Zachary S; Demaria, Sandra; Monjazeb, Arta M; Formenti, Silvia C; Weichselbaum, Ralph R; Welsh, James; Enderling, Heiko; Schoenfeld, Jonathan D; Brody, Joshua D; McGee, Heather M; Mondini, Michele; Kent, Michael S; Young, Kristina H; Galluzzi, Lorenzo; Karam, Sana D; Theelen, Willemijn S M E; Chang, Joe Y; Huynh, Mai Anh; Daib, Adi; Pitroda, Sean; Chung, Caroline; Serre, Raphael; Grassberger, Clemens; Deng, Jie; Sodji, Quaovi H; Nguyen, Anthony T; Patel, Ravi B; Krebs, Simone; Kalbasi, Anusha; Kerr, Caroline; Vanpouille-Box, Claire; Vick, Logan; Aguilera, Todd A; Ong, Irene M; Herrera, Fernanda; Menon, Hari; Smart, DeeDee; Ahmed, Jalal; Gartrell, Robyn D; Roland, Christina L; Fekrmandi, Fatemeh; Chakraborty, Binita; Bent, Eric H; Berg, Tracy J; Hutson, Alan; Khleif, Samir; Sikora, Andrew G; Fong, Lawrence

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Epcoritamab联合GemOx治疗不适合移植的复发/难治性弥漫性大B细胞淋巴瘤:EPCORE NHL-2试验结果

Brody, Joshua D; Jørgensen, Judit; Belada, David; Costello, Régis; Trněný, Marek; Vitolo, Umberto; Lewis, David John; Karimi, Yasmin H; Sureda, Anna; André, Marc; Wahlin, Björn E; Lugtenburg, Pieternella J; Jiang, Tony; Karagoz, Kubra; Steele, Andrew J; Abbas, Aqeel; Wang, Liwei; Risum, Malene; Cordoba, Raul

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

与替代皮质类固醇方案相比,地塞米松作为复发/难治性大B细胞淋巴瘤患者接受格洛菲单抗治疗前的预用药,可降低细胞因子释放综合征的发生频率和严重程度。

Falchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L; Salar, Antonio; Brody, Joshua D; Leppä, Sirpa; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel

Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumors

通过增强 Fas/FasL 信号传导来增强 CAR-T 细胞的旁观者杀伤作用,可以减轻异质性肿瘤中的抗原逃逸现象。

Lin, Matthew J; Chorazeczewski, Joanna K; Pantsulaia, Gvantsa; Cooper, Alan; Sohn, Moah; Reci, Sidorela; Mateus-Tique, Jaime; Hirsh, Nicole H; Xie, Xinping; Odak, Ivan; Dutta, Rudra; Charytonowicz, Daniel; Upadhyay, Ranjan; Brown, Brian D; Merad, Miriam; Huse, Morgan; Kline, Justin; Brody, Joshua D

Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

癌症免疫治疗学会 (SITC) 关于肿瘤内免疫治疗临床试验 (IICT) 的建议:从癌前病变到转移性疾病

Luke, Jason J; Davar, Diwakar; Andtbacka, Robert H; Bhardwaj, Nina; Brody, Joshua D; Chesney, Jason; Coffin, Robert; de Baere, Thierry; de Gruijl, Tanja D; Fury, Matthew; Goldmacher, Gregory; Harrington, Kevin J; Kaufman, Howard; Kelly, Ciara M; Khilnani, Anuradha D; Liu, Ke; Loi, Sherene; Long, Georgina V; Melero, Ignacio; Middleton, Mark; Neyns, Bart; Pinato, David J; Sheth, Rahul A; Solomon, Stephen B; Szapary, Philippe; Marabelle, Aurelien

Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors

GS-3583(一种FMS样酪氨酸激酶3激动剂Fc融合蛋白)在晚期实体瘤患者中的I期研究

Tolcher, Anthony W; Brody, Joshua D; Rajakumaraswamy, Nishanthan; Kuhne, Michelle; Trowe, Torsten; Dauki, Anees M; Pai, Shantheri; Han, Ling; Lin, Kai-Wen; Petrarca, Michael; Kummar, Shivaani

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

纳武利尤单抗联合维布妥昔单抗治疗复发/难治性外周T细胞淋巴瘤和皮肤T细胞淋巴瘤

Zinzani, Pier Luigi; Salles, Gilles; Moskowitz, Alison J; Santoro, Armando; Mehta, Amitkumar; Barr, Paul M; Mehta-Shah, Neha; Collins, Graham P; Ansell, Stephen M; Brody, Joshua D; Domingo-Domenech, Eva; Johnson, Nathalie A; Cunningham, David; Ferrari, Silvia; Lisano, Julie; Krajewski, Jennifer; Wen, Rachael; Akyol, Alev; Crowe, Russell; Savage, Kerry J

End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?

弥漫性大B细胞淋巴瘤临床试验的终点:是时候进行更多对话了吗?

Degtyarev, Evgeny; Bolaños, Natacha; Brody, Joshua D; Buchbinder, Aby; Buyse, Marc; Fuchs, Miriam; Halabi, Susan; Hemmings, Robert; Masood, Aisha; Newsome, Simon; Saxton, Claire; Warwick, Lorna; Yateman, Nigel A; Zuber, Emmanuel

Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming

病原体疫苗中的模式识别受体激动剂介导抗肿瘤T细胞交叉启动

Aleynick, Mark; Svensson-Arvelund, Judit; Pantsulaia, Gvantsa; Kim, Kristy; Rose, Samuel A; Upadhyay, Ranjan; Yellin, Michael; Marsh, Henry; Oreper, Daniel; Jhunjhunwala, Suchit; Moussion, Christine Carine; Merad, Miriam; Brown, Brian D; Brody, Joshua D